S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ANEB Anebulo Pharmaceuticals Inc

1.52

-0.01 (-0.65%)

Last Updated: 03:32:34

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Anebulo Pharmaceuticals (NASDAQ:ANEB)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Anebulo Pharmaceuticals Charts.

Anebulo Pharmaceuticals (NASDAQ:ANEB)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Anebulo Pharmaceuticals Charts.

Anebulo Pharmaceuticals Inc News

Form 8-K - Current report
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
Tuesday 24 December 2024 (1 month ago) • Business Wire

Form 8-K - Current report
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
Thursday 14 November 2024 (3 months ago) • Business Wire

Form 8-K - Current report
Thursday 17 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 26 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 26 September 2024 (4 months ago) • Edgar (US Regulatory)

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
Thursday 26 September 2024 (4 months ago) • Business Wire

Form 8-K - Current report
Monday 22 July 2024 (7 months ago) • Edgar (US Regulatory)

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects
Monday 22 July 2024 (7 months ago) • Business Wire

Lifecore Biomedical Announces Cooperation Agreement with 22NW
Monday 1 July 2024 (7 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (8 months ago) • Edgar (US Regulatory)

More Anebulo Pharmaceuticals Inc News Articles

Terrain Minerals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions